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Abstract
Tracheobronchopathia osteochondroplastica (TBO) is a rare disease of unknown etiology characterised by a formation of multiple, 
cartilaginous and osteocartilaginous submucosal nodules in the trachea and major bronchi. The course of the disease is usually 
benign but the narrowing of the respiratory tract can lead to chronic non-specific clinical symptoms.
We present a case of a 50-year old man with chronic exertional dyspnoea and stenosis of the trachea visible in imaging tests, in 
whom the symptoms were caused by TBO. 
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Streszczenie
Tracheobronchopatia osteochondroplastyczna (TBO) jest rzadką chorobą o niejasnej etiologii, charakteryzującą się powstawaniem 
mnogich, chrzęstnych i chrzęstno-kostnych guzków w błonie podśluzowej tchawicy i dużych oskrzeli. Przebieg kliniczny choroby 
jest zwykle łagodny, ale zwężenie dróg oddechowych może powodować przewlekłe, niespecyficzne objawy kliniczne.
Przedstawiono przypadek 50-letniego mężczyzny z przewlekłą dusznością wysiłkową i widocznym w badaniach obrazowych 
zwężeniem tchawicy. Przyczyną objawów była TBO.
Słowa kluczowe: tracheobronchopatia osteochondroplastyczna, zwężenie tchawicy, choroby dróg oddechowych
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Introduction
Tracheobronchopathia osteochondroplastica 
(TBO) is a rare disease of unknown etiology char-
acterised by the formation of cartilaginous and 
osteocartilaginous submucosal nodules in the air-
ways [1−3]. Lesions, usually multiple, are located 
in the distal part of the trachea and major bronchi. 
They project into the lumen of the airways causing 
their narrowing and clinical symptoms [3, 4]. 
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We present a case of a patient with a few 
years’ history of exertional dyspnoea, in whom 
chest imaging tests revealed tracheal stenosis.
Case report
A fifty-year old male was admitted to the 
Department of Pneumonology in June 2013 due to 
tracheal stenosis, which was first visible on chest 
x-ray and confirmed by computed tomography 
(CT). He had a few years’ history of exertional 
dyspnoea and infections of the respiratory system 
recurring several times a year with intensification 
of dyspnoea and a long-lasting productive cough. 
Furthermore, he suffered from frequent epistaxis. 
In addition, he had arterial hypertension, hepatic 
cirrhosis of mixed etiology (toxic/HBV infection) 
and secondary thrombocytopenia. Over 20 years 
ago he was treated with cartilage autograft due to 
ozaena. He never smoked cigarettes. 
On admission to the Department, the patient 
was in good general condition, without symptoms 
of respiratory failure. During physical examina-
tion, the following deviations from the norm were 
found: obesity (BMI = 34), a scar in the right 
hypogastrium due to appendectomy, scars after 
collecting cartilage for nasal septum graft from the 
right costal arch. Chest percussion was normal, 
and auscultation revealed vesicular breath sound. 
Laboratory tests showed thrombocytopenia and 
elevated glucose and transaminases levels in 
blood serum. 
Lung function tests did not reveal ventila-
tion disorders such as obstruction or restriction, 
impairment of diffusion capacity of the lungs for 
carbon monoxide (DLCO) was not found, exercise 
tolerance in 6-minute walking test (6MWT) was 
correct (Table 1). The patient was examined by 
a laryngologist, who apart from epistaxis in Kies-
selbach plexus on the left side, found nodules in 
the proximal part of the trachea. Bronchofibro-
scopy revealed a narrow, bilaterally flattened, 
non-compliant trachea, with multiple hard pol-
ypoidal formations covered with a smooth mu-
cous membrane that caused narrowing of the 
lumen. The membranous wall of the trachea had 
no pathological lesions. Lesions of similar mor-
phology were visible in the major bronchi, right 
superior lobar and intermediate bronchi; they 
led to the narrowing of their distal parts, which 
made impossible to insert the apparatus beyond 
the narrowing (Fig. 1). Fragments of the mucous 
membrane of the bronchi, which were covered 
with ciliated epithelium, occasionally with squa-
mous metaplasia, were found in samples col-
lected from the lesions; whereas in submucosa 
a small fragment of bone was found. No amyloid 
concrements were present. In order to definitely 
exclude amyloidosis, next tests were carried out. 
No abnormal proteins or Bence-Jones protein 
in the urine were found, daily urinary protein 
excretion and levels of kappa and lambda light 
chains in the urine were correct. The abdominal 
skin and subcutaneous fat-pad biopsy did not 
show any pathology, no amyloid deposits were 
identified by histochemical staining (Congo red). 
A radiologist was consulted regarding chest CT. 
It showed multisegmental deformities of tracheal 
cartilage that projected into its lumen causing ste-
nosis of the trachea. In the narrowest place, about 
70 mm above the tracheal bifurcation, lumen of 
the trachea was only 4−5 mm wide. Many carti-
lages, particularly those situated in the proximal 
part of the trachea were calcified (Fig. 2).
Basing on the above examinations, the patient 
was diagnosed with tracheobronchopathia osteo-
chondroplastica. Due to correct lung function tests 
Figure 1. Brochoscopy appears multiple firm nodules located in the 
anterolateral tracheal wall (A) and main bronchi (B). The posterior 
membranous wall of trachea is spared
A
B
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Figure 2. A CT images reveal narrowing of trachea (A) and main bron-
chi (B) with multiple protruding nodules and calcifications in their walls
three independent authors: Rokitansky, Luschka 
and Wilks [1, 3, 5]. In the past, multiple sub-
mucosal cartilaginous and osteocartilaginous 
nodules in the trachea and major bronchi were 
diagnosed during autopsy. Currently, in many 
cases TBO is also found no earlier than during 
postmortem examination [5−7]. However, be-
cause bronchofiberoscopy is becoming more and 
more common in clinical practice, the disease is 
more frequently diagnosed intravitally [3]. It is 
difficult to estimate its prevalence. At autopsy, in 
various populations, its prevalence varies from 
1:400 to 3:1000 cases. During a bronchoscopy, 
typical lesions are revealed in 0.017% to 0.7% 
of procedures [2−4, 8, 9]. TBO occurs usually in 
individuals over 50 years of age, frequently in the 
sixth or seventh decade of life, however, it may 
also affect younger people [1−3, 9, 10]. There are 
reports of the disease occurring even in 9- and 
11-year old girls [6, 11]. No dependence was found 
between the disease incidence and sex [1, 6, 9, 10, 12]. 
There is no relationship for cigarette smoking 
and TBO [9], some authors have postulated its 
more frequent incidence in persons with ozaena, 
similarly as in the case of the patient described 
in the present work [2, 6].
Apart from the fact that the clinical symp-
toms of TBO are not pathognomonic, many sub-
jects do not present any symptoms at all. The 
disease is detected then by accident e.g. during 
a bronchofiberoscopy performed for other rea-
sons, random chest imaging studies or a difficult 
intubation [6, 13−15]. If clinical signs occur, they 
depend on the size of the lesions and their place 
of occurrence [1, 2]. The most frequent are exer-
tional dyspnoea, chronic cough, expectoration, 
which is often abundant, and occasionally hae-
moptysis. In some patients, recurring infections 
of the lower airways are what predominates 
[2, 5, 3, 9, 16−18]. Many of them are first diagnosed 
with asthma or chronic bronchitis [2, 3, 10, 19]. 
Whereas others seek medical attention due to 
voice alteration or chronic hoarseness [5, 6, 20]. 
Physical examination usually does not show any 
changes [8, 17]. Sometimes the following signs 
are found above the lung fields: wheezing, stridor, 
crepitations [9, 10]. 
Chest x-ray is generally correct [1, 3, 12]. In 
the advanced phase of the disease (as in the case 
of our patient), narrowing or displacement of the 
trachea is visible, with marked irregular outline of 
its walls [10, 4, 12]. Chest CT provides definitely 
more information, which shows as follows: thick-
ening of the cartilage of the trachea and bronchi, 
the presence of segmental calcificafions along 
A
B
results, we resigned from thoracic surgery and 
mechanical removal of lesions from the airways, 
instead, we decided to observe the patient. 
He was admitted to the Department six months 
later. Spirometric and bodyplethysmographic 
parameters were comparable to those collected 
previously, the distance covered during six minute 
walking test — 6MWT was extended (Table 1). 
Lesions visible on chest CT scan, in compar-
ison with the examination conducted 11 months 
ago, did not alter. The patient consulted a thoracic 
surgeon again. Decision was made to continue 
conservative treatment and follow-up. 
Discussion
Typical TBO lesions were described for the 
first time in the first half of the 19th century by 
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Table 1. Pulmonary function tests results
June 2013 January 2014
FEV1 99.2% 96.1%
VC 101.2% 103.9% 
TLC 103.3% 103.0%
RV 104.2% 104.3%
DLCO SB 81.9% −
DLCO VA 90.4% −
6 MWT
   distance
   desaturation
   dyspnoe before test









Pulmonary function tests results are showed as a percentage of a predictive 
value; FEV1 — forced expiratory volume in one second; VC — vital capacity; 
TLC — total lung capacity; RV — residual volume; DLCO SB — single-breath 
diffusing capacity of the lung for carbon monoxide; DLCO/VA — single-breath 
diffusing capacity of the lung for carbon monoxide corrected for alveolar volu-
me; 6 MWT — 6 minute walking test 
their internal surface, multiple calcified nodules 
not enhanced after contrast, which project into 
their lumen. Lesions may be visible within the 
lower airways, from the larynx down to the pe-
ripheral bronchi, but most frequently they occur 
in 2/3 of the distal trachea and proximal bronchi. 
The posterior wall of the trachea remains free 
from the lesions [2−4, 20−22]. The CT technique 
which allows to visualise the airways well is 
a virtual bronchoscopy [2]. 
Lung function tests usually do not show air-
flow limitation [1, 8, 10, 18]. Only a small fraction 
of patients presents ventilation abnormalities, 
most commonly bronchial obstruction [1, 10, 12]. 
If they appear, the changes in lung function tests 
are the most sensitive way of evaluation of the 
disease progression [1].
Blood tests, including morphological and 
biochemical, do not prove useful for diagnosis. 
Calcium and phosphorus metabolism remains 
unchanged [3, 8].
Bronchofiberoscopy is the most important ex-
amination that allows to diagnose the disease [1]. 
According to some authors, currently, it al-
lows to diagnose 90% of TBO cases [12]. In the 
lower airways, there are multiple whitish hard 
nodules located on the anterior and lateral wall 
of the trachea, often linked with the cartilages. 
They are usually warty, sometimes they merge 
together or take a form of plates. If they occur 
in large numbers, they look like paving stones 
[1, 7, 12, 17]. Lesions usually affect distal part 
of the trachea, however, they may occur on its 
all length, also in the major, lobar or segmental 
bronchi [1, 5, 7, 10, 23]. It is a rare phenomenon 
that isolated peripheral lesion causes narrowing 
of the bronchi to the extent that atelectasis occurs 
[13, 24]. There was a report of a patient, in whom 
a single tracheal mass in the lumen of the trachea 
was found [25]. 
The posterior wall of the trachea is usu-
ally free from pathological lesions and this is 
a symptom which differs TBO from other disor-
ders affecting the airways such as amyloidosis 
[1, 3, 4, 9, 26]. However, there are few reports of le-
sions located also in this part of the trachea [8, 7]. 
It is believed that the airways appearance in 
bronchofiberoscopy is so typical that it alone is di-
agnostic of the disease. Histopathological examina-
tion is not required [1−3]. Furthermore, because 
the nodular lesions are very hard, it is difficult 
to collect material for microscopic examination, 
although it allows to exclude other diseases such 
as amyloidosis, neoplasms or papillomas [2, 3]. 
Histopathological images usually reveal submu-
cosal cartilaginous nodules, sometimes with cal-
cification and ossification foci. Fatty marrow islets 
may also occur within the nodules, on occasion 
even with haematopoesis [5, 7, 22, 24, 27]. The 
nodules are usually linked to the cartilaginous 
tracheal and bronchial rings, but they may also 
be separated from them [5, 7, 8, 22]. Lesions are 
generally covered with a proper mucous mem-
brane, however, they occasionally show signs of 
thinning with squamous metaplasia or the features 
of chronic inflammation [3, 7, 20, 27]. 
Prognosis in TBO is mostly good. Although 
cases of rapid, lasting a few months [27] or even 
weeks [28] progression of the disease have been 
reported, in most cases, it is benign. The signs 
may be of similar intensity for years, and even 
periodically alleviate or disappear completely 
for the period of several months or years [6, 12]. 
There is a report of a patient who had no clinical 
signs for 25 years of follow-up [8].
There is no specific therapy for the disorder 
as it is impossible to eliminate all lesions or 
prevent development of new ones. Due to gen-
erally mild course of the disease, treatment is 
applied only in the case of intensive signs. Then 
it consists of humidification of the airways, 
avoidance of exposure to irritating agents and 
prompt treatment of infections of the respira-
tory system [1, 3]. In some patients, improve-
ment has been achieved after administration 
of a bronchodilator [3]. Solely in the case of 
intensive narrowing of the airways, the attempts 
of mechanical removal of lesions are made using 
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forceps during laryngoscopy or bronchoscopy, or 
guillotining using a rigid bronchoscope. Other 
methods include stent implantation at the place 
of narrowing, laser ablation and cryotherapy 
[2, 3, 9, 10, 29]. In some patients, improvement 
was achieved thanks to radiotherapy [1, 3]. 
These methods usually lead to alleviation of the 
symptoms and improvement of the lung func-
tion tests, however, sometimes complications 
occur in the form of secondary narrowing of the 
airways [9]. There are also cases reporting the 
course of the disease, during which a signifi-
cant stenosis occurred, which required thoracic 
surgery. Surgical treatment include: larynx 
resection, segmental resection of the trachea, 
tracheoplasty [3, 27, 30]. In the case of lesions in 
the lung parenchyma or long-lasting bronchial 
obstruction, removal of changed fragments of 
the lung may be necessary [13, 24].
Conclusions
Tracheobronchopathia osteochondroplas-
tica is a rare disorder of the lower airways, 
usually with a mild clinical course. However, it 
should be borne in mind as in some patients it 
may contribute to the occurrence of significant 
clinical signs and have a vital impact on patients’ 
quality of life.
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